Majority of younger patients dying of cancer use aggressive interventions in last month of life
the ONA take:
According to a recent study published in JAMA Oncology, researchers at Dana-Farber Cancer Institute/Boston Children's Cancer and Blood Disorders Center and Kaiser Permanente Southern California have found that more than two-thirds of adolescents and young adults dying as a result of cancer underwent at least one aggressive intervention during the last month of life.
For the study, researchers evaluated the use of intensive care, the emergency room, chemotherapy, and/or hospitalization in the last month of life in 633 patients aged 15 to 39 years who died of cancer between 2001 and 2010.
Results showed that young patients were more than two times as likely as patients 65 and older to receive intensive care and/or use the emergency room during the last month of life. The rate of use of chemotherapy and hospitalization was similar among both age groups. Researchers found that 22% of the adolescents and young adults used intensive care and/or the emergency room in the last month of life, 11% received chemotherapy in the last two weeks of life, and 62% were hospitalized in the last month of life.
The findings suggest that further research is warranted to determine whether younger patients dying of cancer have been adequately supported to make their end-of-life decisions.
More than two-thirds of adolescents and young adults dying as a result of cancer underwent at least one aggressive intervention during the last month of life.
Sign Up for Free e-newsletters
- A Witness to Letting Go: Nursing Care at the End of Life
- CHEMO-SUPPORT: A Nursing Intervention to Relieve Chemotherapy Symptom Burden
- Risk for Cardiovascular Disease Higher in Survivors of Testicular Cancer
- Sexual Quality of Life Decreased During, After Chemotherapy for Digestive Cancers
- Age Not a Deterrent to Immunotherapy for Malignant Melanoma
- Various Aspects of Palliative Care Focus Associated With Different Outcomes In Cancer
- Cost vs Benefits: The Controversy Over Proton Beam Radiotherapy
- Patient Expectations at Odds With Actual Outcomes for Radiotherapy in Breast Cancer
- Patients Desire More Online Tools and Access
- Metformin Plus Ruxolitinib: A Potential Therapeutic Alternative for Myeloproliferative Neoplasms
- Patients With Head and Neck Cancer Have Greater Chance of Being Prescribed Opioids
- Medical Terms in Patient Education: Using the Confusing to Explain the Complicated
- Bedside Assessment Tool Improves Worst Pain in Patients With Cancer
- Androgen-Deprivation Therapy for Prostate Cancer May Cause Nocturia, Sleep Disturbance
- USPSTF Rates Ovarian Cancer Screening a D for Asymptomatic, Low-Risk Women
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|